As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 5/13/24  Nymox Pharmaceutical Corp.        6-K         5/13/24    2:20K                                    Pubco Reporting … Inc/FA 
 3/28/24  Nymox Pharmaceutical Corp.        6-K         3/28/24    2:712K                                   Pubco Reporting … Inc/FA 
11/15/23‡ Nymox Pharmaceutical Corp.        6-K         9/30/23   45:2.1M                                   Pubco Reporting … Inc/FA 
 11/9/23  Nymox Pharmaceutical Corp.        6-K         11/9/23    2:30K                                    Pubco Reporting … Inc/FA 
 11/6/23  Nymox Pharmaceutical Corp.        6-K         11/3/23    6:136K                                   Pubco Reporting … Inc/FA 
10/26/23  Nymox Pharmaceutical Corp.        6-K        10/26/23    2:28K                                    Pubco Reporting … Inc/FA 
 9/25/23  Nymox Pharmaceutical Corp.        6-K         9/25/23    2:25K                                    Pubco Reporting … Inc/FA 
 8/29/23  Nymox Pharmaceutical Corp.        6-K         8/29/23    2:28K                                    Pubco Reporting … Inc/FA 
 8/14/23  Nymox Pharmaceutical Corp.        6-K         6/30/23   46:2.2M                                   Pubco Reporting … Inc/FA 
  8/2/23  Nymox Pharmaceutical Corp.        6-K          8/2/23    2:26K                                    Pubco Reporting … Inc/FA 
 7/31/23  Nymox Pharmaceutical Corp.        6-K         7/31/23    2:1.1M                                   Pubco Reporting … Inc/FA 
 7/25/23  Nymox Pharmaceutical Corp.        6-K         7/25/23    3:1.1M                                   Pubco Reporting … Inc/FA 
 7/25/23  Nymox Pharmaceutical Corp.        6-K         7/25/23    2:1.1M                                   Pubco Reporting … Inc/FA 
 7/12/23  Nymox Pharmaceutical Corp.        6-K         7/12/23    2:30K                                    Pubco Reporting … Inc/FA 
  7/6/23‡ Nymox Pharmaceutical Corp.        6-K          7/5/23    2:27K                                    Pubco Reporting … Inc/FA 
 6/29/23  Nymox Pharmaceutical Corp.        6-K         6/29/23    1:10K                                    Pubco Reporting … Inc/FA 
 6/29/23  Nymox Pharmaceutical Corp.        6-K/A       6/28/23    1:11K                                    Pubco Reporting … Inc/FA 
 6/27/23  Nymox Pharmaceutical Corp.        6-K         6/27/23    1:10K                                    Pubco Reporting … Inc/FA 
 5/12/23  Nymox Pharmaceutical Corp.        6-K         3/31/23   45:1.8M                                   Pubco Reporting … Inc/FA 
  5/2/23  Nymox Pharmaceutical Corp.        20-F       12/31/22  105:5.5M                                   Pubco Reporting … Inc/FA 

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	6-K	Current, Quarterly or Annual Report by a Foreign Issuer — Form 6-K.
	20-F	Annual or Annual-Transition Report by a Foreign Non-Canadian Issuer — Form 20-F.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.